At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 126 enrolled
Drug / intervention
Aspart fixed dose +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prandial Insulin Dosing Using the Carbohydrate Counting Technique in Hospitalized Patients With Diabetes
In Brief
A Phase 4 clinical trial evaluating Aspart fixed dose and Aspart flexible dose for Diabetes and 2 related conditions. Completed, enrolled 126 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether mealtime insulin results in better control of blood sugar than a fixed meal dose in hospitalized patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes, Admitting Hospital, Non-critically Ill
CountriesUnited States
CollaboratorsNovo Nordisk A/S
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 2010
Enrollment StartJun 2010
Primary CompletionJun 2012
Study CompletionMar 2013
TodayJul 2026
First PostedApr 12, 2010
Enrollment StartJun 1, 2010
Primary CompletionJun 1, 2012
Study CompletionMar 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 16.2 years ago
Interventions
Aspart fixed dosedrug
fixed dose
Aspart flexible dosedrug
dose based upon carbohydrate intake and total daily requirements